INTRODUCTION
The 5-year survival rate for children and adolescents with cancer in many high-income countries now exceeds 80%, as exemplified in Canada. 1 For those with the commonest form of malignant disease in this age group-acute lymphoblastic leukemia (ALL)-the rate now approximates 90%. 2 However, many of these survivors experience long-term adverse sequelae (late effects) of their disease and its treatment. In the case of ALL, these effects include alterations in body composition (notably obesity) that carry a burden of morbidity and early mortality. 3 Much less attention has been paid to the loss of lean body mass (LBM) and especially its major component, skeletal muscle mass (SMM), which leads to sarcopenia in patients with cancer 4 and contributes to the phenomenon of frailty that has been described in young adult survivors of ALL. 5 Accordingly, we have undertaken a study of body composition, with an emphasis on SMM, in long-term survivors of ALL in childhood and adolescence.
In our comprehensive study of body composition and bone health in long-term survivors of ALL in childhood and adolescence (more than 10 years after the diagnosis), 6 numerous elements are directed to the assessment of the nutritional status. A previous report 7 describes the findings with respect to the body mass index (BMI) and arm anthropometry. The latter consisted of the mid-upper arm circumference (MUAC) and the triceps skin-fold thickness (TSFT). These were selected as surrogate measures of LBM (which closely approximates fat-free mass) and fat mass (FM), respectively, as proposed by Frisancho. 8 BMI does not distinguish muscle from adipose tissue. 9 By contrast, direct measurements of LBM, FM, and appendicular lean mass (ALM; a major component of SMM) are accomplished with dual-energy x-ray absorptiometry (DXA), as described in healthy Canadian children 10, 11 and in those with ALL on treatment.
12,13
The current report addresses the a priori hypotheses that 1) LBM would be low and FM would be high in longterm survivors of ALL in childhood and adolescence, 2) a specific deficit in SMM would be identifiable, with a population of survivors demonstrating the paradox of sarcopenic obesity, and 3) in this clinical context, the significant correlations of MUAC with LBM (and SMM) and TSFT with FM would be confirmed. Moreover, it was hypothesized that sarcopenic obesity would have an adverse impact on health-related quality of life (HRQL).
MATERIALS AND METHODS
Details of the design of the comprehensive study have been published. 6 In summary, from a cohort of children and adolescents who had been diagnosed at McMaster Children's Hospital with ALL a decade or more previously, a study sample of 75 subjects (37 males and 38 females) was assembled (Fig. 1) . All had received therapy according to protocols of the Dana-Farber Cancer Institute Childhood ALL Consortium, 14 of which McMaster Children's Hospital was a member. The great majority were white. At the time of the study, the subjects ranged in age from 13.5 to 38.5 years (median, 21.2 years).
Whole-body DXA scans were obtained with a Hologic densitometer (Discovery A; Hologic, Inc, Bedford, Massachusetts). Measures of the LBM, FM, and wholebody bone mineral content were obtained and summed for comparison with the directly measured total body weight. As we have shown previously, 10 the sum of these compartments of body composition correspond almost exactly to the total body weight in healthy children. Absolute values and z scores for the percent body fat were obtained with the densitometer.
The fat-free mass index (FFMI) and the fat mass index (FMI), adjusting LBM and FM, respectively, for height, were generated from the DXA scans on the basis of the approach proposed by Van Itallie et al 15 with bioelectrical impedance analysis. This approach was used more recently to develop reference values with DXA in National Health and Nutrition Examination Surveys. 16 The subjects were classified with respect to body fat according to World Health Organization criteria based on BMI and matching prevalences of FMI. 16 Corresponding BMI values for the subjects were taken from our earlier report. This acknowledges that ALM constitutes 73% to 75% of SMM. In healthy subjects, our measurement of SMM has a precision of 170 g with a 95% confidence interval of 138 to 223 g; the reproducibility, expressed as a coefficient of variation, is 1.0%. 11 Again, height-normalized values were generated. 19 The Hologic instrument provided absolute values and z scores for the FFMI, FMI, and appendicular lean mass index (ALMI), with the last adjusted for height just as the other indices were. For the subjects who were 18 years old, z scores were generated for SMM with our normative data set.
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The arm anthropometry measures were taken from our previous report 7 to allow correlational analyses of MUAC with LBM and ALM and of TSFT with FM together with the corresponding indices.
Measures of HRQL were taken from another previous report 20 using the Health Utilities Index, which is a collection of multi-attribute, preference-based instruments developed at McMaster University. 21 The Health Utilities Index Mark 2 (HUI2) and the Health Utilities Index Mark 3 (HUI3) are complementary systems. With published preference functions, utility scores are determined for individual attributes as well as multi-attribute overall HRQL (the comprehensive health state) for each subject. 22 Single attribute scores range from 1.00 (no limitations) to 0.00 (the lowest level of function), and overall HRQL scores range from 1.00 (perfect health) to 0.00 (equivalent to being dead). Clinically meaningful differences in utility scores are 0.05 for single attributes 23 and 0.03 for overall HRQL. 24 
Statistical Analyses
Descriptive statistics (medians, minimums, maximums, means, and standard deviations of the mean) were used to 
RESULTS
Demographic and clinical details of the study population are provided in Supporting Table 1 (see online supporting  information) . The values for body composition in the 3-compartment model are given in Supporting Table 2 (see online supporting information). The correlation between the sum of these compartments and the directly measured body weight was almost perfect (r 5 0.998). The corresponding height-normalized indices for the FM and fatfree mass (ie, LBM) are displayed in Table 1 .
With the FMI ranges that correspond to World Health Organization categories based on BMI, the classification of the study population is demonstrated in Table  2 . Few females and no males had deficits in body fat. The majority of females and two-thirds of males were overweight/obese, with 12% and 18%, respectively, being obese. The corresponding proportions in the study population on the basis of BMI, as reported earlier, 17 were 35.3% of females and 31.3% of males who were overweight/obese (5.9% and 9.8% were obese).
The analysis of ALM and the derived values for SMM are presented in Table 3 . Fifty percent of the subjects who were 18 years old had z scores for SMM less than -0.9. Clearly, the distributions of FM and SMM are different in this population of young cancer survivors; the average z scores are positive for the former and negative for the latter. In the absence of a widely accepted quantitative definition of sarcopenic obesity, the number of subjects with positive z scores for FMI and negative scores for ALMI was identified (n 5 32 [43%]). A notable sex disparity was apparent, with 18 of the 37 males (49%) and 14 of the 38 females (37%) exhibiting sarcopenic obesity. There were no statistically significant differences in body composition between survivors who had been cranially irradiated and those who had not been (Table 4) . Furthermore, there was no significant difference in height centiles between these 2 groups. Both had individuals in the <3rd and >97th centiles, whereas 23 of the 51 irradiated subjects (45%) and 12 of the 23 nonirradiated subjects (52%) were in the range of the 25th to 75th centiles. As for surrogate measures of body composition provided by arm anthropometry, the correlation of MUAC was strong with LBM (fat-free mass; r 5 0.665, P < .0001) and likewise ALM (r 5 0.672, P < .0001). The correlations with FFMI (r 5 0.282, P 5 .0156) and ALMI (r 5 0.369, P 5 .0013) were weaker but still highly statistically significant. TSFT correlated strongly with FM (r 5 0.633, P < .0001) and percent body fat (r 5 0.788, P < .0001) but also with FMI (r 5 0.651, P < .0001).
Information on HRQL and its associations with sarcopenic obesity is provided in Table 5 . There were clinically important differences between subjects with sarcopenic obesity and those without sarcopenic obesity, notably in Sensation and Emotion (HUI2) and in Hearing, Emotion, and Cognition (HUI3). This represents a notably greater burden of morbidity in the sarcopenically obese population. The overall HRQL (HUI3) was statistically significantly lower in the group with sarcopenic obesity and approached significance with HUI2. No differences were discernible in the HUI2 attributes of Mobility, Pain, and Self-Care or in the HUI3 attributes of Ambulation and Pain. The differential burdens in Sensation, Hearing, Emotion (HUI2 and HUI3), and Cognition were not attributable to cranial irradiation (P 5 .316, P 5 .619, P 5 .280, and P 5 .490, respectively), although it approached significance for Emotion in HUI3 (P 5 .073), and there was no difference in overall HRQL between the sarcopenically obese populations that were and were not cranially irradiated (P 5 .800).
DISCUSSION
Sarcopenic obesity in survivors of cancer places them in double jeopardy: they face the adverse effects of excess body fat on health (eg, metabolic syndrome) 3 and are at risk for premature frailty 5 on the basis of inadequate SMM. The results of the current study reveal that this apparently paradoxical phenotype is exhibited by a considerable proportion of long-term survivors of ALL in childhood and adolescence. Whether there is truly a higher prevalence in males versus females will require study in a larger cohort; a larger cohort will also be needed for studies of body composition in long-term survivors who did or did not undergo cranial irradiation. In the study reported here, the composite of lower FM, lean mass, and muscle mass is not typical of a growth hormone deficiency, which is usually associated with increased FM. 25 As described by Orgel et al, 26 the process leading to sarcopenic obesity begins early during the treatment of ALL and is progressive during therapy. These investigators also used DXA and defined sarcopenic obesity on the basis of discordance between body fat (percent body fat) and fat-free mass (LBM) in a serial study of 50 children and adolescents who were mainly (80%) of Hispanic ethnicity. A loss of muscle mass during the treatment of ALL in children has been recognized for more than 25 years. 27 It is likely that this is related, in large measure, to the use of high-dose glucocorticosteroid therapy. A loss of an average of 10% of LBM in 2 months was demonstrated in 33 adults who were treated with a glucocorticosteroid for a variety of inflammatory disorders. 28 In our study of 91 children with ALL, the mean SMM z score diminished by 0.77 between diagnosis and 6 months of therapy. 13 Such a loss of muscle mass is due to degradation and decreased synthesis of the myosin heavy chain, the most important contractile protein in muscle. 29 Moreover, steroid use is also associated with increased glycogen and lipid levels in muscle cells. 30, 31 As described by Heymsfield et al, 32 a loss of muscle volume is associated with quantifiable changes in muscle composition that have an impact on strength and physical performance, as exemplified in sarcopenic obesity. Indeed, compromised function in upper and lower limbs was demonstrated in 15 children with ALL via hand-grip strength and "time up and go" testing, respectively, by the end of remission induction therapy. 33 Using a 4 compartment model of body composition, other investigators have described the fat-free mass (similar to LBM) in 24 survivors of ALL as being similar to that of their healthy peers approximately 4 years after the completion of therapy, although this compartment showed greater hydration and lower density in comparison with the control subjects. 34 Ness et al 35 observed a modest but statistically significant reduction (2%-3%) in SMM in comparison with controls in 75 survivors of ALL who were on average 25 years from their diagnosis. In a group of 20 subjects for whom it had been at least 3 years since hematopoietic stem cell transplantation for ALL in childhood, Wei et al 36 demonstrated a sarcopenic phenotype in the majority.
The finding of a greater burden of morbidity, as reflected in poorer HRQL, in the group of study participants who were sarcopenically obese is clinically notable. It is relevant that other investigators have called for an approach using utility weighting, as provided by preference-based instruments such as the Health Utilities Index, to assess HRQL in the context of sarcopenic obesity among the elderly. 37 Studies of small numbers of postmenopausal women (n 5 9 and n 5 11) 38,39 using a non-preference-based measure (36-Item Short Form Health Survey) have produced contrary results. By contrast, studies in large samples of the general population of Korean adults (almost 1000 and 2000 with sarcopenic obesity), assessed with a measure of utility (EQ-5D), demonstrated a significant deficit in HRQL in those with sarcopenic obesity, 40 which was associated with multiple morbidities. 41 A continuing challenge in studies of sarcopenic obesity is the absence of a consensus on a quantitative definition. This is no better demonstrated than in a subsample of almost 5000 subjects older than 60 years in the National Health and Nutrition Examination Surveys (1999) (2000) (2001) (2002) (2003) (2004) . 42 According to 8 definitions, the prevalence of sarcopenic obesity ranged from 4.4% to 84.0% in men and from 3.6% to 94.0% in women. Similar challenges have been described for studies that included subjects as young as 20 years. 43 Of course, this limitation applies to the current study. The approach comparing FMI with ALMI indicated that close to half of the subjects could be defined as exhibiting sarcopenic obesity. Using a similar approach for comparing FMI with FFMI, investigators in Switzerland and Germany demonstrated that, in a population of more than 1700 hospitalized adults, the length of stay was longest for those with a high FMI and a low FFMI. 44 Other limitations of the current study are the sample of subjects and the cross-sectional design. Although a sample size of 75 is greater than that of some other studies of long-term survivors of ALL in childhood and adolescence, the question of representativeness must be addressed. The inability to recruit 35% of the eligible subjects (41 of 116) because they had not attended the long-term follow-up clinic in more than a year raises the possibility that those who were missing were healthier than the participants.
Although a cross-sectional design has its limitations, it does provide a snapshot of prevalence. Clearly, this population of adolescents and young adults must be reevaluated as they age because FM increases and LBM decreases in older adult life. 45 Such concerns demand that awareness be heightened and that strategies for the prevention/amelioration of the premature-aging phenotype in such survivors be developed and put to the test. The challenges in doing so have been well described, 46 and efforts to date have met with mixed results, 47 although a recent study offers hope for improvement. 48 In that report, children who had completed treatment for a variety of cancers were offered a 6-month, group-based exercise program. Those who did participate showed significantly greater gains in motor performance and overall activity than those who did not participate. Moreover, there were no adverse events among the participants, and they gained more emotional well-being than the nonparticipants did. Future studies should be conducted as randomized controlled trials with additional outcome measures, including an assessment of body composition.
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